You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, April 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas

Eric C. Vonderheid, MD; Pieter C. van Voorst Vader, MD

Arch Dermatol. 1980;116(4):408-412.


Abstract

{dagger} The overall frequency of herpes zoster-varicella (HZV) infection in 221 patients with histologically confirmed cutaneous T-cell lymphoma was 10% (22 patients). The frequency of HZV infection and serious complications (viral dissemination, bacteremia) was relatively high in patients with evidence of extracutaneous involvement, especially in patients with Sézary syndrome. The major factors identified to account for this predisposition to HZV infection include intensive treatment with radiation therapy or drugs given for systemic effect and/or immunologic deficiency consequent to advanced disease. These observations are quite similar to those made in patients with Hodgkin's disease.

(Arch Dermatol 116:408-412, 1980)



Author Affiliations

From the Skin and Cancer Hospital, Department of Dermatology, Temple University School of Medicine, Philadelphia. Dr van Voorst Vader is a visiting member of the Dutch Mycosis Fungoides Study Group, Free University Hospital, the Netherlands.


Footnotes

Accepted for publication Oct 8, 1979.

Reprint requests to the Skin and Cancer Hospital, 3322 N Broad St, Philadelphia, PA 19140 (Dr Vonderheid).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results
Duvic et al.
JCO 2001;19:2456-2471.
ABSTRACT | FULL TEXT  

Infections Complicating Mycosis Fungoides and Sezary Syndrome
Axelrod et al.
JAMA 1992;267:1354-1358.
ABSTRACT  

Pre-Sezary Erythroderma Evolving to Sezary Syndrome: A Report of Seven Cases
Buechner and Winkelmann
Arch Dermatol 1983;119:285-291.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.